Department of Chemistry, University of Pavia, Via Taramelli 12, 27100, Pavia, Italy.
ChemMedChem. 2021 May 18;16(10):1593-1599. doi: 10.1002/cmdc.202000960. Epub 2021 Feb 18.
Advances in genomics and proteomics have unveiled an ever-growing number of key proteins and provided mechanistic insights into the genesis of pathologies. This wealth of data showed that changes in expression levels of specific proteins, mutations, and post-translational modifications can result in (often subtle) perturbations of functional protein-protein interaction networks, which ultimately determine disease phenotypes. Although many such validated pathogenic proteins have emerged as ideal drug targets, there are also several that escape traditional pharmacological regulation; these proteins have thus been labeled "undruggable". The challenges posed by undruggable targets call for new sorts of molecular intervention. One fascinating solution is to perturb a pathogenic protein's expression levels, rather than blocking its activities. In this Concept paper, we shall discuss chemical interventions aimed at recruiting undruggable proteins to the ubiquitin proteasome system, or aimed at disrupting protein-protein interactions in the chaperone-mediated cellular folding machinery: both kinds of intervention lead to a decrease in the amount of active pathogenic protein expressed. Specifically, we shall discuss the role of computational strategies in understanding the molecular determinants characterizing the function of synthetic molecules typically designed for either type of intervention. Finally, we shall provide our perspectives and views on the current limitations and possibilities to expand the scope of rational approaches to the design of chemical regulators of protein levels.
基因组学和蛋白质组学的进展揭示了越来越多的关键蛋白质,并为病理学的发生提供了机制上的见解。这些丰富的数据表明,特定蛋白质表达水平的变化、突变和翻译后修饰会导致(通常是微妙的)功能蛋白-蛋白相互作用网络的扰动,而这些网络最终决定了疾病表型。尽管许多这样经过验证的致病性蛋白质已成为理想的药物靶点,但也有一些蛋白质逃避传统的药理学调节;这些蛋白质因此被标记为“不可成药”。不可成药靶点带来的挑战需要新的分子干预手段。一种引人入胜的解决方案是改变致病蛋白的表达水平,而不是阻断其活性。在这篇概念论文中,我们将讨论旨在将不可成药蛋白募集到泛素蛋白酶体系统中的化学干预,或旨在破坏伴侣介导的细胞折叠机制中的蛋白-蛋白相互作用的化学干预:这两种干预都会导致表达的活性致病蛋白数量减少。具体来说,我们将讨论计算策略在理解通常为这两种干预中的任何一种设计的合成分子的功能的分子决定因素方面的作用。最后,我们将提供我们对当前限制和扩大合理方法设计蛋白质水平化学调节剂范围的可能性的看法。